Xconomy’s Digital Events →
December 3, 2020 · New York
Nick Leschly is CEO of Bluebird Bio
Sponsored · Whitepaper
Knowing the volume of procedures and growth trends by site of care can allow you to understand the market demand for your product
Create well-controlled, biologically relevant test systems and validate them to support FDA approvals
Sponsored · Webinar
Provide an in vitro drug-induced proarrhythmia assessment & strengthen pharmacological safety profiles of drug candidates
© 2007-2020, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.